E
Eric J. Feuer
Researcher at National Institutes of Health
Publications - 237
Citations - 50596
Eric J. Feuer is an academic researcher from National Institutes of Health. The author has contributed to research in topics: Population & Cancer. The author has an hindex of 71, co-authored 226 publications receiving 45885 citations. Previous affiliations of Eric J. Feuer include Fred Hutchinson Cancer Research Center & University of Texas MD Anderson Cancer Center.
Papers
More filters
Journal ArticleDOI
The efficacy of prostate-specific antigen screening: Impact of key components in the ERSPC and PLCO trials.
Harry J. de Koning,Roman Gulati,Sue Moss,Jonas Hugosson,Paul F. Pinsky,Christine D. Berg,Anssi Auvinen,Gerald L. Andriole,Monique J. Roobol,E. David Crawford,Vera Nelen,Maciej Kwiatkowski,Marco Zappa,Marcos Lujan,Arnauld Villers,Tiago M. de Carvalho,Eric J. Feuer,Alexander Tsodikov,Angela B. Mariotto,Eveline A.M. Heijnsdijk,Ruth Etzioni +20 more
TL;DR: In this paper, the authors calibrated 2 microsimulation models to individual-level incidence and mortality data from 238,936 men participating in the European Randomized Study of Screening for Prostate Cancer (ERSPC) and PLCO trials.
Journal ArticleDOI
Life tables adjusted for comorbidity more accurately estimate noncancer survival for recently diagnosed cancer patients.
TL;DR: The health-adjusted age and the life tables adjusted by age, race, sex, and comorbidity can provide important information to facilitate decision making about treatment for cancer and other conditions.
Journal ArticleDOI
Additional common inputs for analyzing impact of adjuvant therapy and mammography on U.S. mortality.
TL;DR: This chapter describes the common input parameters that were common to all the Cancer Intervention and Surveillance Modeling Network (CISNET) models participating in the breast cancer base case.
Journal ArticleDOI
Improvement in the diagnostic evaluation of a positive fecal occult blood test in an integrated health care organization.
Diana L. Miglioretti,Carolyn M. Rutter,Susan Carol Bradford,Ann G. Zauber,Larry G. Kessler,Eric J. Feuer,David C. Grossman +6 more
TL;DR: Adherence to recommendations for complete diagnostic evaluation after a positive FOBT has greatly improved over time in an integrated group medical practice and it may be possible to reach levels of follow-up that are comparable to those observed in randomized trials.
Journal ArticleDOI
The impact of stage and histology on the long-term clinical course of 163,808 patients with breast carcinoma
TL;DR: Stage and histologic type have a significant impact on the long term clinical course of breast carcinoma, and estimates of these components can be derived only by using survival models that incorporate cured fraction as a specific parameter.